Beta Bionics, Inc. (BBNX)
(Delayed Data from NSDQ)
$21.13 USD
-1.21 (-5.42%)
Updated Oct 15, 2025 04:00 PM ET
After-Market: $21.12 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Beta Bionics, Inc. has a market cap of $971.12M, which represents its share price of $22.34 multiplied by its outstanding shares number of 43.47M. As a small-cap company, BBNX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BBNX 21.13 -1.21(-5.42%)
Will BBNX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for BBNX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BBNX
BBNX Stock May Gain From Abbott Deal to Advance iLet Integration
BBNX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BBNX
20 Day Moving Average Support appears for BBNX after 0.86% move
Crossed Above 20 Day Moving Average appears for BBNX after 5.33% move
Is BBNX signaling selling opportunity? 20 Day Moving Average Resistance shows up after crashing 5.4%
Is BBNX positioned for a breakdown? 20 Day Moving Average Resistance shows up after gaining 0.45%
BBNX forms 20 Day Moving Average Resistance on October 8